CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients,…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

CENTOGENE highlights solutions for early diagnosis of rare hereditary disorders at the 2nd Annual Recent Advances in Rare Disease Conference.

CENTOGE…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, announced the publication…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference…

There are more than 7,000 identified rare diseases where about 80% are hereditary. About 30 million Americans are living with a rare disease today;…

We mark Rare Disease Day 2018 with continued commitment to reduce time to diagnosis of rare diseases.

Prof. Arndt Rolfs has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a dedicated group of technology…

One of the website for rare disease community - Rare Disease Report has shared exciting news about CentoMD® mutation database milestone - one billion…

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads